SCHEMBL6976684

SCHEMBL6976684

O=C(CCN1CCCCC1)Cc1ccc(F)cc1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
POLB P06746 1/20 0.53
MAPT P10636 1/20 0.53
SCN5A Q14524 1/20 0.47
KMT2A Q03164 3/20 0.46
MCHR1 Q99705 2/20 0.46
HRH3 Q9Y5N1 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
GFER P55789 1/20 0.45
HSD11B1 P28845 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13227206 0.86 ALDH1A1 (0.56) ALDH1A1POLBMAPTSCN5AKMT2A
SCHEMBL27710646 0.86 ALDH1A1 (0.55) ALDH1A1POLBMAPTKMT2ASMN1; SMN2
SCHEMBL8491361 0.84 ALDH1A1 (0.61) ALDH1A1POLBMAPTKMT2ASIGMAR1
SCHEMBL11122002 0.83 ALDH1A1 (0.71) ALDH1A1MAPTHRH3TSHRSMN1; SMN2
SCHEMBL14227975 0.83 ALDH1A1 (0.50) ALDH1A1POLBMAPTKMT2ASMN1; SMN2
SCHEMBL6614327 0.80 CYP3A4 (0.48) ALDH1A1KMT2ASMN1; SMN2
SCHEMBL11755100 0.78 ALDH1A1 (0.71) ALDH1A1POLBMAPTKMT2AHRH3
Hydrochloric Acid SCHEMBL9766013 0.77 SIGMAR1 (0.60) SIGMAR1
SCHEMBL9200146 0.76 ALDH1A1 (0.50) ALDH1A1POLBMAPTKMT2ATSHR
SCHEMBL7374163 0.76 HRH3 (0.58) ALDH1A1SCN5AKMT2AHRH3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296949-A2 PIPERIDINE AMIDES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Bristol-Myers Squibb Pharma Company (US) 2003-04-02 EP disclosed
WO-2001098268-A2 PIPERIDINE AMIDES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-12-27 WO disclosed